Skip to main content
Top
Published in: Inflammation 2/2019

01-04-2019 | ORIGINAL ARTICLE

MicroRNA let-7c Improves LPS-Induced Outcomes of Endometritis by Suppressing NF-κB Signaling

Authors: Gan Zhao, Tao Zhang, Haichong Wu, Kangfeng Jiang, Changwei Qiu, Ganzhen Deng

Published in: Inflammation | Issue 2/2019

Login to get access

Abstract

Endometritis is a common inflammatory disease which endangers human and animal reproductive health. MicroRNA (miRNA) let-7c plays an important role in the inflammatory process; however, the regulatory underlying mechanism of let-7c in endometritis is unclear. In this study, we confirmed that let-7c was significantly reduced in LPS-induced mouse endometritis model, and overexpression of let-7c was able to effectively reduce uterine tissue damage caused by lipopolysaccharide (LPS), and then, a LPS-induced bovine endometrial epithelial cell (BEND) line was used to mimic the inflammatory model in vitro. Our data showed that overexpression of let-7c significantly reduced the expression of pro-inflammatory cytokines in BEND cells induced by LPS. Meanwhile, immunofluorescence and western blotting results showed that let-7c significantly inhibited LPS-induced phosphorylation of NF-κB, thereby inhibiting downstream pro-inflammatory cytokine expression. Taken together, our results suggested that let-7c ameliorates LPS-induced endometritis by attenuating the expression of pro-inflammatory cytokines via inhibition of the activation of NF-κB.
Appendix
Available only for authorised users
Literature
5.
go back to reference Didier, Heumann, and Thierry Roger. 2002. Initial responses to endotoxins and Gram-negative bacteria. Clinica Chimica Acta 323 (1–2): 59–72. Didier, Heumann, and Thierry Roger. 2002. Initial responses to endotoxins and Gram-negative bacteria. Clinica Chimica Acta 323 (1–2): 59–72.
17.
go back to reference Nicholas, Courtney, Sanjay Batra, Melissa A. Vargo, Oliver H. Voss, Mikhail A. Gavrilin, Mark D. Wewers, Denis C. Guttridge, Erich Grotewold, and Andrea I. Doseff. 2007. Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-κB through the suppression of p65 phosphorylation. Journal of Immunology 179 (10): 7121–7127. https://doi.org/10.4049/jimmunol.179.10.7121.CrossRef Nicholas, Courtney, Sanjay Batra, Melissa A. Vargo, Oliver H. Voss, Mikhail A. Gavrilin, Mark D. Wewers, Denis C. Guttridge, Erich Grotewold, and Andrea I. Doseff. 2007. Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-κB through the suppression of p65 phosphorylation. Journal of Immunology 179 (10): 7121–7127. https://​doi.​org/​10.​4049/​jimmunol.​179.​10.​7121.CrossRef
21.
go back to reference Hailemariam, D., S. Ibrahim, M. Hoelker, M. Drillich, W. Heuwieser, C. Looft, M.U. Cinar, E. Tholen, K. Schellander, and D. Tesfaye. 2014. MicroRNA-regulated molecular mechanism underlying bovine subclinical endometritis. Reproduction, Fertility, and Development 26 (6): 898–913. https://doi.org/10.1071/rd13027.CrossRefPubMed Hailemariam, D., S. Ibrahim, M. Hoelker, M. Drillich, W. Heuwieser, C. Looft, M.U. Cinar, E. Tholen, K. Schellander, and D. Tesfaye. 2014. MicroRNA-regulated molecular mechanism underlying bovine subclinical endometritis. Reproduction, Fertility, and Development 26 (6): 898–913. https://​doi.​org/​10.​1071/​rd13027.CrossRefPubMed
Metadata
Title
MicroRNA let-7c Improves LPS-Induced Outcomes of Endometritis by Suppressing NF-κB Signaling
Authors
Gan Zhao
Tao Zhang
Haichong Wu
Kangfeng Jiang
Changwei Qiu
Ganzhen Deng
Publication date
01-04-2019
Publisher
Springer US
Published in
Inflammation / Issue 2/2019
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-018-0922-4

Other articles of this Issue 2/2019

Inflammation 2/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.